Angum, F., Khan, T., Kaler, J., Siddiqui, L. and Hussain, A. (2020). The Prevalence of Autoimmune Disorders in Women: A Narrative Review. Cureus, [online] 12(5). doi:https://doi.org/10.7759/cureus.8094.
Autoimmune Association (2021). Graves’ disease. [online] Autoimmune Association. Available at: https://autoimmune.org/disease-information/graves-disease/#:~:text=A%20distinguishing%20characteristic%20of%20Graves.
Bartalena, L. and Fatourechi, V. (2014). Extrathyroidal manifestations of Graves’ disease: a 2014 update. Journal of Endocrinological Investigation, [online] 37(8), pp.691–700. doi:https://doi.org/10.1007/s40618-014-0097-2.
Cleveland Clinic (2020). Graves’ Disease: Symptoms, Causes, Treatments & Tests. [online] Cleveland Clinic. Available at: https://my.clevelandclinic.org/health/diseases/15244-graves-disease.
Cleveland Clinic (2022a). Graves’ Disease: What It Is, Causes, Symptoms & Treatment. [online] Cleveland Clinic. Available at: https://my.clevelandclinic.org/health/diseases/15244-graves-disease#:~:text=People%20who%20receive%20definitive%20treatment.
Cleveland Clinic (2022b). Pretibial Myxedema (Graves’ Dermopathy): Causes & Treatment. [online] Cleveland Clinic. Available at: https://my.clevelandclinic.org/health/diseases/24514-pretibial-myxedema.
De Leo, S., Lee, S.Y. and Braverman, L.E. (2017). Hyperthyroidism. The Lancet, [online] 388(10047), pp.906–918. doi:https://doi.org/10.1016/s0140-6736(16)00278-6.
Fatourechi, V., Ahmed, D.D.F. and Schwartz, K.M. (2002). Thyroid Acropachy: Report of 40 Patients Treated at a Single Institution in a 26-Year Period. The Journal of Clinical Endocrinology & Metabolism, 87(12), pp.5435–5441. doi:https://doi.org/10.1210/jc.2002-020746.
Földes, J., Petrányi, G., Takó, J., Bános, C., Krasznai, I., Horváth, C. and Steczek, K. (1983). Serum calcitonin in hyperthyroidism. Acta Medica Hungarica, [online] 40(2-3), pp.99–105. Available at: https://pubmed.ncbi.nlm.nih.gov/6689443/.
Franco, J.-S., Amaya-Amaya, J. and Anaya, J.-M. (2013). Thyroid disease and autoimmune diseases. [online] www.ncbi.nlm.nih.gov. El Rosario University Press. Available at: https://www.ncbi.nlm.nih.gov/books/NBK459466/.
Geffner, D.L. and Hershman, J.M. (1992). Beta-adrenergic blockade for the treatment of hyperthyroidism. The American Journal of Medicine, [online] 93(1), pp.61–68. doi:https://doi.org/10.1016/0002-9343(92)90681-z.
Ginsberg, J. (2003). Diagnosis and management of Graves’ disease. CMAJ : Canadian Medical Association journal = journal de l’Association medicale canadienne, [online] 168(5), pp.575–85. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC149254/.
HealthCentral (2018) Graves’ Disease Diagnosis, HealthCentral. Available at: https://www.healthcentral.com/condition/graves-disease/graves-disease-diagnosis [Accessed: 06 June 2023].
Hou, J., Tang, Y., Chen, Y. and Chen, D. (2021). The Role of the Microbiota in Graves’ Disease and Graves’ Orbitopathy. Frontiers in Cellular and Infection Microbiology, 11. doi:https://doi.org/10.3389/fcimb.2021.739707.
Hussain, Y.S., Hookham, J.C., Allahabadia, A. and Balasubramanian, S.P. (2017). Epidemiology, management and outcomes of Graves’ disease—real life data. Endocrine, [online] 56(3), pp.568–578. doi:https://doi.org/10.1007/s12020-017-1306-5.
Kahaly, George J., Bartalena, L., Hegedüs, L., Leenhardt, L., Poppe, K. and Pearce, Simon H. (2018). 2018 European Thyroid Association Guideline for the Management of Graves’ Hyperthyroidism. European Thyroid Journal, [online] 7(4), pp.167–186. doi:https://doi.org/10.1159/000490384.
Mayo Clinic (2020). Graves’ disease - Symptoms and causes. [online] Mayo Clinic. Available at: https://www.mayoclinic.org/diseases-conditions/graves-disease/symptoms-causes/syc-20356240#:~:text=Graves.
Mayo Clinic (2020b). Hyperthyroidism - Symptoms and causes. [online] Mayo Clinic. Available at: https://www.mayoclinic.org/diseases-conditions/hyperthyroidism/symptoms-causes/syc-20373659.
McIver, B. and Morris, J.C. (1998). The pathogenesis of Graves’ disease. Endocrinology and metabolism clinics of North America, [online] 27(1), pp.73–89. doi:https://doi.org/10.1016/s0889-8529(05)70299-1.
Mumtaz, M., Lin, L.S., Hui, K.C. and Mohd Khir, A.S. (2009). Radioiodine I-131 for the therapy of graves’ disease. The Malaysian journal of medical sciences : MJMS, [online] 16(1), pp.25–33. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3336179.
National Institute of Diabetes and Digestive and Kidney Diseases (2019). Graves’ Disease. [online] NIDDK. Available at: https://www.niddk.nih.gov/health-information/endocrine-diseases/graves-disease.
National Institute of Diabetes and Digestive and Kidney Diseases. (n.d.). Graves’ Disease | NIDDK. [online] Available at: https://www.niddk.nih.gov/health-information/endocrine-diseases/graves-disease#symptoms.
National Institute of Diabetes and Digestive and Kidney Diseases. (n.d.). Thyroid Disease & Pregnancy | NIDDK. [online] Available at: https://www.niddk.nih.gov/health-information/endocrine-diseases/pregnancy-thyroid-disease#:~:text=Hyperthyroidism%20in%20pregnancy%20is%20usually.
Nauman, J. (2013). Etiopathogenesis of Graves-Basedow disease; where we are and where we are going. Thyroid Research, 6(S2). doi:https://doi.org/10.1186/1756-6614-6-s2-a43.
News-Medical.net. (2012). Causes of Graves’ disease. [online] Available at: https://www.news-medical.net/health/Causes-of-Graves-disease.aspx.
Osuna, P.M., Udovcic, M. and Sharma, M.D. (2017). Hyperthyroidism and the Heart. Methodist DeBakey Cardiovascular Journal, [online] 13(2), pp.60–63. doi:https://doi.org/10.14797/mdcj-13-2-60.
Panaitescu, A. (2018). Fetal Goitre in Maternal Graves’ Disease. Acta Endocrinologica (Bucharest), [online] 14(1), pp.85–89. doi:https://doi.org/10.4183/aeb.2018.85.
Ploski, R., Szymanski, K. and Bednarczuk, T. (2011). The Genetic Basis of Graves Disease. Current Genomics, [online] 12(8), pp.542–563. doi:https://doi.org/10.2174/138920211798120772.
Rodriguez, D. (2014). Are You at Risk for Thyroid Disease? [online] EverydayHealth.com. Available at: https://www.everydayhealth.com/thyroid-conditions/evaluating-your-thyroid-disease-risk.aspx.
Stasiak, M., Zawadzka-Starczewska, K., Tymoniuk, B., Stasiak, B. and Lewiński, A. (2023). Significance of HLA in the development of Graves’ orbitopathy. Genes & Immunity, 24(1), pp.32–38. doi:https://doi.org/10.1038/s41435-023-00193-z.
Song, E., Koo, M.J., Noh, E., Hwang, S.Y., Park, M.J., Kim, J.A., Roh, E., Choi, K.M., Baik, S.H., Cho, G.J. and Yoo, H.J. (2021). Risk of Diabetes in Patients with Long-Standing Graves’ Disease: A Longitudinal Study. Endocrinology and Metabolism, [online] 36(6), pp.1277–1286. doi:https://doi.org/10.3803/enm.2021.1251.
The Harley Street ENT (n.d.). Why Women Are More Prone to Thyroid Problems? | Harley Street ENT Clinic. [online] www.harleystreetent.com. Available at: https://www.harleystreetent.com/blog/why-women-are-more-prone-to-thyroid-problems#:~:text=The%20risk%20for%20women%20is.
Tun, N.N.Z., Beckett, G., Zammitt, N.N., Strachan, M.W.J., Seckl, J.R. and Gibb, F.W. (2016). Thyrotropin Receptor Antibody Levels at Diagnosis and After Thionamide Course Predict Graves’ Disease Relapse. Thyroid, 26(8), pp.1004–1009. doi:https://doi.org/10.1089/thy.2016.0017.
VinMec International Hospital (n.d.). Why is Graves’ disease more common in women than in men? [online] www.vinmec.com. Available at: https://www.vinmec.com/en/news/health-news/general-health-check/why-is-graves-disease-more-common-in-women-than-in-men/.
Weerakkody, Y., Glick, Y. and Ashraf , A. (2010). Graves disease | Radiology Reference Article | Radiopaedia.org. [online] Radiopaedia. Available at: https://radiopaedia.org/articles/10695.
Wiersinga, W.M. (2016). Clinical Relevance of Environmental Factors in the Pathogenesis of Autoimmune Thyroid Disease. Endocrinology and Metabolism, 31(2), p.213. doi:https://doi.org/10.3803/enm.2016.31.2.213.
Yeung, S.-C.J. (2023). Graves Disease: Practice Essentials, Pathophysiology, Epidemiology. eMedicine. [online] Available at: https://emedicine.medscape.com/article/120619-overview#a2.